Insider · CIK 0001746742

Ozawa Clare

Reports to the SEC for 1 company · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001746742

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-03	Oyster Point Pharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−11.1K sh	—	—	3,573
2023-01-03	Oyster Point Pharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−3,573 sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.U Disposition from Tender	Director	UDisposition from Tender	−415K sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.U Disposition from Tender	Director	UDisposition from Tender	−2,465 sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.U Disposition from Tender	Director	UDisposition from Tender	−2.24M sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.U Disposition from Tender	Director	UDisposition from Tender	−1M sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,359 sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,199 sh	—	—	0
2022-06-06	Oyster Point Pharma, Inc.A Award	Director	AAward	+3,573 sh	—	—	14,637
2022-06-06	Oyster Point Pharma, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,359 sh	—	—	5,359
2022-01-05	Oyster Point Pharma, Inc.J Other	Director	JOther	−200K sh	—	—	414,607
2022-01-05	Oyster Point Pharma, Inc.J Other	Director	JOther	+51.6K sh	—	—	51,556
2022-01-05	Oyster Point Pharma, Inc.J Other	Director	JOther	−51.6K sh	—	—	0
2022-01-05	Oyster Point Pharma, Inc.J Other	Director	JOther	+120 sh	—	—	11,064
2022-01-05	Oyster Point Pharma, Inc.J Other	Director	JOther	−1,261 sh	—	—	2,465
2021-12-21	Oyster Point Pharma, Inc.J Other	Director	JOther	−200K sh	—	—	614,820
2021-12-21	Oyster Point Pharma, Inc.J Other	Director	JOther	+51.6K sh	—	—	51,556
2021-12-21	Oyster Point Pharma, Inc.J Other	Director	JOther	−51.6K sh	—	—	0
2021-12-21	Oyster Point Pharma, Inc.J Other	Director	JOther	+120 sh	—	—	10,944
2021-12-21	Oyster Point Pharma, Inc.J Other	Director	JOther	−1,261 sh	—	—	3,726
2021-10-18	Oyster Point Pharma, Inc.S Sale	Director	SSale	−304K sh	$14.63	−$4.44M	1,057,976
2021-10-18	Oyster Point Pharma, Inc.S Sale	Director	SSale	−1,912 sh	$14.63	−$28K	6,518
2021-10-18	Oyster Point Pharma, Inc.S Sale	Director	SSale	−243K sh	$15.09	−$3.67M	815,033
2021-10-18	Oyster Point Pharma, Inc.S Sale	Director	SSale	−1,531 sh	$15.09	−$23.1K	4,987
2021-06-07	Oyster Point Pharma, Inc.A Award	Director	AAward	+3,466 sh	—	—	10,824
2021-06-07	Oyster Point Pharma, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,199 sh	—	—	5,199
2021-05-12	Oyster Point Pharma, Inc.J Other	Director	JOther	−320K sh	—	—	1,361,590
2021-05-12	Oyster Point Pharma, Inc.J Other	Director	JOther	+82.5K sh	—	—	82,486
2021-05-12	Oyster Point Pharma, Inc.J Other	Director	JOther	−82.5K sh	—	—	0
2021-05-12	Oyster Point Pharma, Inc.J Other	Director	JOther	+193 sh	—	—	7,358
2021-05-12	Oyster Point Pharma, Inc.J Other	Director	JOther	−2,018 sh	—	—	8,430
2021-03-26	Oyster Point Pharma, Inc.J Other	Director	JOther	−320K sh	—	—	1,681,930
2021-03-26	Oyster Point Pharma, Inc.J Other	Director	JOther	+82.5K sh	—	—	82,491
2021-03-26	Oyster Point Pharma, Inc.J Other	Director	JOther	−82.5K sh	—	—	0
2021-03-26	Oyster Point Pharma, Inc.J Other	Director	JOther	+193 sh	—	—	7,165
2021-03-26	Oyster Point Pharma, Inc.J Other	Director	JOther	−1,990 sh	—	—	10,448
2021-02-17	Oyster Point Pharma, Inc.J Other	Director	JOther	−325K sh	—	—	2,236,888
2021-02-17	Oyster Point Pharma, Inc.J Other	Director	JOther	+6,500 sh	—	—	6,500
2021-02-17	Oyster Point Pharma, Inc.J Other	Director	JOther	−6,500 sh	—	—	0
2021-02-17	Oyster Point Pharma, Inc.J Other	Director	JOther	+5,607 sh	—	—	5,607
2021-02-17	Oyster Point Pharma, Inc.J Other	Director	JOther	−5,607 sh	—	—	0
2021-02-17	Oyster Point Pharma, Inc.J Other	Director	JOther	+372 sh	—	—	6,972
2020-06-08	Oyster Point Pharma, Inc.A Award	Director	AAward	+6,600 sh	—	—	6,600
2019-11-04	Oyster Point Pharma, Inc.C Conversion	Director	CConversion	+1.94M sh	—	—	1,941,500
2019-11-04	Oyster Point Pharma, Inc.C Conversion	Director	CConversion	+495K sh	—	—	2,436,888
2019-11-04	Oyster Point Pharma, Inc.P Purchase	Director	PPurchase	+125K sh	$16.00	+$2M	2,561,888
2019-11-04	Oyster Point Pharma, Inc.C Conversion	Director	CConversion	+566K sh	—	—	566,158
2019-11-04	Oyster Point Pharma, Inc.P Purchase	Director	PPurchase	+438K sh	$16.00	+$7M	1,003,658
2019-11-04	Oyster Point Pharma, Inc.Series A Convertible Preferred StockC Conversion	Director	CConversion	−1.94M sh	—	—	0
2019-11-04	Oyster Point Pharma, Inc.Series B Convertible Preferred StockC Conversion	Director	CConversion	−495K sh	—	—	0

Recent filings

Accepted (ET)
Jan 44
Ozawa Clare0001209191-23-001088
SEC(opens sec.gov)
Jun 84
Ozawa Clare0001209191-22-035067
SEC(opens sec.gov)
Jan 74
Ozawa Clare0000899243-22-001359
SEC(opens sec.gov)
Dec 234
Ozawa Clare0000899243-21-049597
SEC(opens sec.gov)

Companies

Oyster Point Pharma, Inc.Director

Address

C/O OYSTER POINT PHARMA, INC. 202 CARNEGIE CENTER, SUITE 109

PRINCETON, NJ, 08540